Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression
George S. Melchor, Tahiyana Khan, Joan Reger, et al.
ACS Pharmacology & Translational Science (2019) Vol. 2, Iss. 6, pp. 372-386
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation
Brittney A. Beyer, Mingliang Fang, Benjamin Sadrian, et al.
Nature Chemical Biology (2017) Vol. 14, Iss. 1, pp. 22-28
Open Access | Times Cited: 95
The beneficial role of autophagy in multiple sclerosis: Yes or No?
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Autophagy (2023) Vol. 20, Iss. 2, pp. 259-274
Open Access | Times Cited: 29
The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, ‏Hebatallah M. Saad, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1671-1682
Closed Access | Times Cited: 27
The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disorders
Aradhana Prajapati, Sidharth Mehan, Zuber Khan
Biogerontology (2023) Vol. 24, Iss. 4, pp. 493-531
Closed Access | Times Cited: 22
Molecular Mechanisms of Central Nervous System Axonal Regeneration and Remyelination: A Review
Akiko Uyeda, Rieko Muramatsu
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8116-8116
Open Access | Times Cited: 59
Myeloid cell-associated aromatic amino acid metabolism facilitates CNS myelin regeneration
Jingwen Hu, George S. Melchor, Dimitrios C. Ladakis, et al.
npj Regenerative Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System
Maria Chountoulesi, Costas Demetzos
Brain Sciences (2020) Vol. 10, Iss. 6, pp. 338-338
Open Access | Times Cited: 48
High-throughput screening for myelination promoting compounds using human stem cell-derived oligodendrocyte progenitor cells
Weifeng Li, Cynthia Berlinicke, Yinyin Huang, et al.
iScience (2023) Vol. 26, Iss. 3, pp. 106156-106156
Open Access | Times Cited: 14
Efficacy of a benzothiazole‐based LRRK2 inhibitor in oligodendrocyte precursor cells and in a murine model of multiple sclerosis
Rocío Benítez‐Fernández, Fernando Josa‐Prado, Estefanía Sánchez, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 5
Enhancing Remyelination in Multiple Sclerosis via Muscarinic Acetylcholine Receptor M1
Kenny K. Y. Chen, Eunyoung Park, Khaled S. Abd‐Elrahman
Molecular Pharmacology (2025) Vol. 107, Iss. 4, pp. 100027-100027
Open Access
The Mouse Model of Internal Capsule Demyelination: A Novel Tool for Investigating Motor Functional Changes Caused by Demyelination and for Evaluating Drugs That Promote Remyelination
Reiji Yamazaki, Nobuhiko Ohno
ACTA HISTOCHEMICA ET CYTOCHEMICA (2024) Vol. 57, Iss. 1, pp. 1-5
Open Access | Times Cited: 4
Senescent cell reduction does not improve recovery in mice under experimental autoimmune encephalomyelitis (EAE) induced demyelination
Zeeba Manavi, George S. Melchor, Meghan R Bullard, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis
Ariane Mwema, Giulio G. Muccioli, Anne des Rieux
Journal of Controlled Release (2023) Vol. 364, pp. 435-457
Closed Access | Times Cited: 9
Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs
Walter H. Moos, Douglas V. Faller, Ioannis P. Glavas, et al.
BioResearch open access (2020) Vol. 9, Iss. 1, pp. 94-105
Open Access | Times Cited: 27
Phosphodiesterase 7(PDE7): A unique drug target for central nervous system diseases
Ying Chen, Hao Wang, Wen-Zhi Wang, et al.
Neuropharmacology (2021) Vol. 196, pp. 108694-108694
Closed Access | Times Cited: 18
Primary Progressive Multiple Sclerosis—A Key to Understanding and Managing Disease Progression
Izabela Sempik, Edyta Dziadkowiak, Helena Moreira, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8751-8751
Open Access | Times Cited: 2
The Current Challenges for Drug Discovery in CNS Remyelination
Sonia Balestri, Alice Del Giovane, Carola Sposato, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2891-2891
Open Access | Times Cited: 17
Failed remyelination of the nonhuman primate optic nerve leads to axon degeneration, retinal damages, and visual dysfunction
Nadège Sarrazin, Estelle Chavret-Reculon, Corinne Bachelin, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 10
Open Access | Times Cited: 12
Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis
Dnyandev Gadhave, Vrashabh V. Sugandhi, Chandrakant Kokare
Brain Research (2023) Vol. 1822, pp. 148674-148674
Closed Access | Times Cited: 6
Smoothened/AMP-Activated Protein Kinase Signaling in Oligodendroglial Cell Maturation
Alice Del Giovane, Mariagiovanna Russo, Linda Tirou, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 10
Antioxidant defense enzymes in multiple sclerosis: A 5‐year follow‐up study
Carson Essenburg, Richard W. Browne, Diala Ghazal, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 8, pp. 2338-2347
Closed Access | Times Cited: 4
Alzheimer’s disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT)
Marina S. Boukhvalova, Lorne F. Kastrukoff, Jorge C. G. Blanco
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 4
Impact of calcitriol and PGD2-G-loaded lipid nanocapsules on oligodendrocyte progenitor cell differentiation and remyelination
Ariane Mwema, Viridiane Gratpain, Bernard Učakar, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 11, pp. 3128-3146
Closed Access | Times Cited: 1
The Nano and Artificial Intelligence Effect: Improved Magnetic Resonance Imaging Volumetry for Multiple Sclerosis
Alrayan F. Nahhas, Alaa F. Nahhas, Thomas J. Webster
OpenNano (2024) Vol. 18, pp. 100209-100209
Open Access | Times Cited: 1
ACKR3 Antagonism Enhances the Repair of Demyelinated Lesions Through Both Immunomodulatory and Remyelinating Effects
Laetitia Pouzol, Anna Sassi, Mélanie Tunis, et al.
Neurochemical Research (2024) Vol. 49, Iss. 8, pp. 2087-2104
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top